Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Operating Expenses (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Operating Expenses for 6 consecutive years, with $23.5 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 27.35% to $23.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $81.0 million through Dec 2025, up 3.86% year-over-year, with the annual reading at $81.0 million for FY2025, 3.86% up from the prior year.
  • Operating Expenses hit $23.5 million in Q4 2025 for Rapid Micro Biosystems, up from $19.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $23.5 million in Q4 2025 to a low of $14.7 million in Q1 2021.
  • Historically, Operating Expenses has averaged $19.4 million across 5 years, with a median of $19.5 million in 2024.
  • Biggest five-year swings in Operating Expenses: surged 97.47% in 2021 and later decreased 14.37% in 2023.
  • Year by year, Operating Expenses stood at $19.8 million in 2021, then grew by 9.46% to $21.6 million in 2022, then fell by 14.37% to $18.5 million in 2023, then fell by 0.42% to $18.4 million in 2024, then grew by 27.35% to $23.5 million in 2025.
  • Business Quant data shows Operating Expenses for RPID at $23.5 million in Q4 2025, $19.2 million in Q3 2025, and $19.4 million in Q2 2025.